Tower Research Capital LLC (TRC) - ENVVENO MEDICAL CORPORATION ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ENVVENO MEDICAL CORPORATION
ValueSharesWeighting
Q3 2023$113
-98.9%
21
-99.3%
0.00%
Q2 2023$9,926
+141700.0%
3,223
+106.7%
0.00%
Q1 2023$7
-22.2%
1,559
-16.1%
0.00%
Q4 2022$9
-99.9%
1,858
-29.8%
0.00%
Q3 2022$17,000
+750.0%
2,648
+389.5%
0.00%
Q2 2022$2,0000.0%541
+77.4%
0.00%
Q1 2022$2,000
-60.0%
305
-61.2%
0.00%
Q4 2021$5,0007860.00%
Other shareholders
ENVVENO MEDICAL CORPORATION shareholders Q4 2023
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 401,200$2,556,0002.70%
KINGDON CAPITAL MANAGEMENT, L.L.C. 219,180$1,396,0000.14%
Perceptive Advisors 781,615$4,978,0000.10%
Kepos Capital LP 50,000$319,0000.02%
ARTHUR M. COHEN & ASSOCIATES, LLC 15,000$96,0000.02%
TWO SIGMA INVESTMENTS, LP 33,372$213,0000.00%
TWO SIGMA ADVISERS, LP 49,600$316,0000.00%
WELLS FARGO & COMPANY/MN 2,045$13,0000.00%
NORTHERN TRUST CORP 13,906$89,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ENVVENO MEDICAL CORPORATION shareholders